Seoul National University Hospital
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 501
- Market Cap
- -
- Website
- https://www.snubh.org
Efficacy and Safety of Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome
Not Applicable
Active, not recruiting
- Conditions
- Irritable Bowel Disease
- First Posted Date
- 2024-11-20
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 44
- Registration Number
- NCT06697119
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
Radiofrequency Ablation Using Combined RF Energy Delivery Mode and Octopus Electrodes for Hepatocellular Carcinoma
Not Applicable
Active, not recruiting
- Conditions
- Hepatocellular Carcinoma (HCC)
- First Posted Date
- 2024-11-11
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 159
- Registration Number
- NCT06682377
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Deep Neuromuscular Blockade on Postoperative Pain
Not Applicable
Recruiting
- Conditions
- Neuromuscular Blockade
- Interventions
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 106
- Registration Number
- NCT06679569
- Locations
- 🇰🇷
SNUCH, Seoul, Korea, Republic of
Comparative Analysis of Core Body Temperature Measurement
Not Applicable
Recruiting
- Conditions
- Temperature Change, Body
- First Posted Date
- 2024-11-06
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06677372
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of
Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma
Completed
- Conditions
- Distal CholangiocarcinomaAdjuvant Chemotherapy
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 578
- Registration Number
- NCT06671431
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
Not Applicable
Recruiting
- Conditions
- Ischemic StrokeSmall Vessel Cerebrovascular DiseaseCholesterol, LDLSecondary PreventionCardiovascular Diseases
- Interventions
- Drug: PCSK9 inhibitor
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 4016
- Registration Number
- NCT06649240
- Locations
- 🇰🇷
Daejeon Eulji Medical Center, Daejeon, Korea, Republic of
🇰🇷National Health Insurance Service Ilsan Hospital, Goyang, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
Comparison of Postoperative Quality of Recovery by Anesthetic Method in Patients Undergoing Shoulder Arthroscopy
Not Applicable
Recruiting
- Conditions
- Shoulder Arthroscopy
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 140
- Registration Number
- NCT06638112
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of
Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP Grade
Completed
- Conditions
- Pancreatic CancerNeoadjuvant TherapyPathological Complete Response
- Interventions
- Drug: neoadjuvant therapy
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 462
- Registration Number
- NCT06630481
Outcomes and Prognostic Factors in Hepatopancreatoduodenectomy
Completed
- Conditions
- Hepatopancreaticobiliary (HPB) MalignancyGall Bladder CancerBile Duct CancerPancreatoduodenectomyHepatectomy
- Interventions
- Other: Hepatopancreatoduodenectomy
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06631352
High-dose Chemotherapy with Thiotepa, Busulfan, and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Central Nervous System Lymphoma
Phase 2
Terminated
- Conditions
- Central Nervous System Lymphoma
- Interventions
- First Posted Date
- 2024-10-03
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 17
- Registration Number
- NCT06625359
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath